Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R302648-1mg | 1mg | In stock | $9.90 | |
R302648-5mg | 5mg | In stock | $29.90 | |
R302648-10mg | 10mg | In stock | $39.90 | |
R302648-25mg | 25mg | In stock | $79.90 | |
R302648-50mg | 50mg | In stock | $119.90 | |
R302648-100mg | 100mg | In stock | $189.90 |
Induces ferroptosis; inhibits glutathione peroxidase 4 (GPX4)
Synonyms | (1S,3R)-RSL3 | 1S,3R-RSL3 | (1S,3R)-Methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylate |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | Glutathione peroxidase 4 (GPX4) inhibitor. Induces ferroptosis. Increases lipid peroxidase levelsin vitro. Inhibits tumor formation and progressionin vivo. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Product Description | RSL3 ((1S,3R)-RSL3) is an inhibitor of glutathione peroxidase 4 (GPX4) (ferroptosis activator), reduces the expression of GPX4 protein, and induces ferroptotic death of head and neck cancer cell. RSL3 increases the expression of p62 and Nrf2 and inactivates Keap1 in HN3-rslR cells |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | methyl (1S,3R)-2-(2-chloroacetyl)-1-(4-methoxycarbonylphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-3-carboxylate |
---|---|
INCHI | InChI=1S/C23H21ClN2O5/c1-30-22(28)14-9-7-13(8-10-14)21-20-16(15-5-3-4-6-17(15)25-20)11-18(23(29)31-2)26(21)19(27)12-24/h3-10,18,21,25H,11-12H2,1-2H3/t18-,21+/m1/s1 |
InChi Key | TXJZRSRTYPUYRW-NQIIRXRSSA-N |
Canonical SMILES | COC(=O)C1CC2=C(C(N1C(=O)CCl)C3=CC=C(C=C3)C(=O)OC)NC4=CC=CC=C24 |
Isomeric SMILES | COC(=O)[C@H]1CC2=C([C@@H](N1C(=O)CCl)C3=CC=C(C=C3)C(=O)OC)NC4=CC=CC=C24 |
PubChem CID | 1750826 |
Molecular Weight | 440.88 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
K2413441 | Certificate of Analysis | Nov 04, 2024 | R302648 |
K2413437 | Certificate of Analysis | Nov 04, 2024 | R302648 |
K2413432 | Certificate of Analysis | Nov 04, 2024 | R302648 |
K2413417 | Certificate of Analysis | Nov 04, 2024 | R302648 |
F2403195 | Certificate of Analysis | May 08, 2024 | R302648 |
F2403197 | Certificate of Analysis | May 08, 2024 | R302648 |
F2403196 | Certificate of Analysis | May 08, 2024 | R302648 |
F2403194 | Certificate of Analysis | May 08, 2024 | R302648 |
F2403193 | Certificate of Analysis | May 08, 2024 | R302648 |
K2307215 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307217 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307218 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307228 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307248 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307211 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307210 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307209 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307208 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307206 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307205 | Certificate of Analysis | Oct 30, 2023 | R302648 |
K2307204 | Certificate of Analysis | Oct 30, 2023 | R302648 |
H2323566 | Certificate of Analysis | Aug 02, 2023 | R302648 |
H2323568 | Certificate of Analysis | Aug 02, 2023 | R302648 |
H2323567 | Certificate of Analysis | Aug 02, 2023 | R302648 |
H2323551 | Certificate of Analysis | Aug 02, 2023 | R302648 |
H2323538 | Certificate of Analysis | Aug 02, 2023 | R302648 |
H2323512 | Certificate of Analysis | Aug 02, 2023 | R302648 |
C23161107 | Certificate of Analysis | Mar 09, 2023 | R302648 |
C2317023 | Certificate of Analysis | Mar 09, 2023 | R302648 |
C2317088 | Certificate of Analysis | Mar 09, 2023 | R302648 |
C2317090 | Certificate of Analysis | Mar 09, 2023 | R302648 |
B2320614 | Certificate of Analysis | Dec 30, 2022 | R302648 |
B2320518 | Certificate of Analysis | Dec 30, 2022 | R302648 |
B2320618 | Certificate of Analysis | Dec 30, 2022 | R302648 |
B2320619 | Certificate of Analysis | Dec 30, 2022 | R302648 |
B2320620 | Certificate of Analysis | Dec 30, 2022 | R302648 |
B2320621 | Certificate of Analysis | Dec 30, 2022 | R302648 |
K2212620 | Certificate of Analysis | Sep 02, 2022 | R302648 |
K2212619 | Certificate of Analysis | Sep 02, 2022 | R302648 |
K2212608 | Certificate of Analysis | Sep 02, 2022 | R302648 |
K2212592 | Certificate of Analysis | Sep 02, 2022 | R302648 |
K2212562 | Certificate of Analysis | Sep 02, 2022 | R302648 |
K2212561 | Certificate of Analysis | Sep 02, 2022 | R302648 |
G2220794 | Certificate of Analysis | Jun 17, 2022 | R302648 |
G2220793 | Certificate of Analysis | Jun 17, 2022 | R302648 |
G2220792 | Certificate of Analysis | Jun 17, 2022 | R302648 |
G2220795 | Certificate of Analysis | Jun 17, 2022 | R302648 |
G2220796 | Certificate of Analysis | Jun 17, 2022 | R302648 |
G2220797 | Certificate of Analysis | Jun 17, 2022 | R302648 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 44.09, Max Conc. mM: 100 |
---|---|
Sensitivity | Moisture sensitive |
RIDADR | NONHforallmodesoftransport |
---|
Starting at $64.90
1. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] |
2. Weili Wu, Yingying Zhao, Baifu Qin, Xin Jiang, Chuyue Wang, Rong Hu, Rui Ma, Mong-Hong Lee, Huanliang Liu, Kai Li, Ping Yuan. (2023) Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine, 93 [PMID:37343364] |
3. Zhao Hongting, Zhang Meng, Zhang Jinghua, Sun Zichen, Zhang Wenxin, Dong Weichen, Cheng Chen, Yao Yongzhong, Li Kuanyu. (2023) Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth. Cell and Bioscience, 13 (1): (1-15). [PMID:37179385] |
4. Yu-Chen Chen, Qiong Zheng, Hui Lu, Yi-Xin Zhuang, Ting-Ting Gong, Lie-Feng Ma, Zha-Jun Zhan. (2023) Neuroprotective flavonoids from Epimedium brevicornu by inhibition of ferroptosis. Phytochemistry Letters, 55 (80). [PMID:] |
5. Fan Zhang, Hualong Zhen, Hengshun Cheng, Fengying Hu, Yunfei Jia, Binbin Huang, Minmin Jiang. (2022) Di-(2-ethylhexyl) phthalate exposure induces liver injury by promoting ferroptosis via downregulation of GPX4 in pregnant mice. Frontiers in Cell and Developmental Biology, 10 (1014243). [PMID:36438553] |
1. 孙世博. (2024) Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif. Redox biology, 70 (70): (103050). [PMID:] |
2. Xiaosi Lin , Le Dong, Qing Miao, Zhaobin Huang, Fang Wang. (2024) Cycloheptylprodigiosin from marine bacterium Spartinivicinus ruber MCCC 1K03745T induces a novel form of cell death characterized by Golgi disruption and enhanced secretion of cathepsin D in non-small cell lung cancer cell lines. European Journal of Pharmacology, 无 (974): (176608). [PMID:38663542] |
3. Haoze Song, Jing Liang, Yuanyuan Guo, Yang Liu, Kuiru Sa, Guohong Yan, Wen Xu, Wei Xu, Lixia Chen, Hua Li. (2024) A potent GPX4 degrader to induce ferroptosis in HT1080 cells. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 265 (116110). [PMID:38194774] |
4. Weili Wu, Yingying Zhao, Baifu Qin, Xin Jiang, Chuyue Wang, Rong Hu, Rui Ma, Mong-Hong Lee, Huanliang Liu, Kai Li, Ping Yuan. (2023) Non-canonical role of UCKL1 on ferroptosis defence in colorectal cancer. EBioMedicine, 93 [PMID:37343364] |
5. Zhao Hongting, Zhang Meng, Zhang Jinghua, Sun Zichen, Zhang Wenxin, Dong Weichen, Cheng Chen, Yao Yongzhong, Li Kuanyu. (2023) Hinokitiol-iron complex is a ferroptosis inducer to inhibit triple-negative breast tumor growth. Cell and Bioscience, 13 (1): (1-15). [PMID:37179385] |
6. Yu-Chen Chen, Qiong Zheng, Hui Lu, Yi-Xin Zhuang, Ting-Ting Gong, Lie-Feng Ma, Zha-Jun Zhan. (2023) Neuroprotective flavonoids from Epimedium brevicornu by inhibition of ferroptosis. Phytochemistry Letters, 55 (80). [PMID:] |
7. Fan Zhang, Hualong Zhen, Hengshun Cheng, Fengying Hu, Yunfei Jia, Binbin Huang, Minmin Jiang. (2022) Di-(2-ethylhexyl) phthalate exposure induces liver injury by promoting ferroptosis via downregulation of GPX4 in pregnant mice. Frontiers in Cell and Developmental Biology, 10 (1014243). [PMID:36438553] |